An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia

E. Dawson*, J. F. Powell, M. M. Nothen, M. A. Crocq, M. Lanczik, J. Korner, M. Rietschel, J. Van Os, P. Wright, M. Gill

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)

Abstract

The cytochrome P450 mono-oxygenases are a group of enzymes that metabolize a variety of exogenous and endogenous compounds, some of which are potentially toxic. Individual variations in the metabolism of potential toxins could influence susceptibility to disorders having genetic and environmental components, such as schizophrenia. The frequency of two common mutant alleles of the gene for the cytochrome P450 enzyme debrisoquine-4-hydroxylase (CYP2D6) was determined in 264 Caucasian schizophrenic patients and 217 controls, using the polymerase chain reaction and restriction enzyme digestions. The patient and control samples showed no significant deviation from Hardy-Weinberg equilibrium and the frequency of each mutant allele (CYP2D6A and CYP2D6B) did not differ between patients and controls.

Original languageEnglish
Pages (from-to)215-218
Number of pages4
JournalPsychiatric Genetics
Volume4
Issue number4
DOIs
Publication statusPublished - 1994
Externally publishedYes

Keywords

  • Association study
  • CYP2D6
  • Debrisoquine 4-Hydroxylase
  • Schizophrenia

Fingerprint

Dive into the research topics of 'An association study of debrisoquine hydroxylase (CYP2D6) polymorphisms in schizophrenia'. Together they form a unique fingerprint.

Cite this